Why is Mankind Pharma falling/rising?

As of 18-Jul, Mankind Pharma Ltd's stock price is rising, currently at 2,652.95, reflecting an increase of 22.55 (0.86%). The stock has shown strong performance recently, with a 3.23% increase over the past week and a notable 12.89% rise over the last month. It has outperformed its sector by 1.41% today and has gained consecutively for the last two days, yielding a total return of 1.12% in that period. Despite a significant drop in delivery volume by 54.75% against the 5-day average, the stock remains liquid enough for trading. The company's high management efficiency, indicated by a return on equity (ROE) of 19.25%, low debt-to-equity ratio, and healthy long-term growth in operating profit at an annual rate of 23.44% contribute positively to its recent upward movement.
In the broader market context, Mankind Pharma's performance contrasts sharply with the benchmark, as the Sensex has declined by 0.90% over the past week. While the stock has generated a remarkable 24.66% return over the past year, the overall market (BSE500) has seen negative returns of -0.36% in the same timeframe. This strong performance relative to the market, combined with high institutional holdings at 24.4%, suggests that informed investors are confident in the company's fundamentals, further supporting the stock's rise amidst a generally unfavorable market environment.